James Wiley
Pediatrics · Mobile, ALNPI 1902896004
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $27,030 of the $43,923 with a category attached, or 61.5%. 13 manufacturers reported payments, led by Tris Pharma Inc at 50.7% of the total. Reporting peaked in 2019 at $22,539 and has fallen 85.8% since, to $3,191 in 2025. Among pediatrics clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 647 payments — averaging $67.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tris Pharma Inc$22K
- Ironshore Pharmaceuticals Inc.$13K
- Supernus Pharmaceuticals, Inc.$5K
- Corium, LLC$2K
- Neos Therapeutics, LP$1K
- Adlon Therapeutics L.p.$327
- plus $816 from 7 others
What the payments were for
- Consulting fees$2801%
- Speaking & faculty fees$27,03062%
- Travel & lodging$5,38912%
- Food & beverage$11,07325%
- Education$1310%
- Gifts$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tris Pharma Inc | 188 | $22,280 |
| Ironshore Pharmaceuticals Inc. | 90 | $12,776 |
| Supernus Pharmaceuticals, Inc. | 111 | $4,599 |
| Corium, LLC | 80 | $1,874 |
| Neos Therapeutics, LP | 102 | $1,252 |
| Adlon Therapeutics L.p. | 25 | $327 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $223 |
| Collegium Pharmaceutical, Inc. | 12 | $222 |
| Shire North American Group Inc | 10 | $178 |
| Vertical Pharmaceuticals, LLC | 8 | $142 |
| Rhodes Pharmaceuticals L.p. | 2 | $28 |
| Noven Therapeutics, LLC | 1 | $19 |
| Aytu Biopharma, Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Dyanavel XR$19,358
- Quillichew ER$13,116
- Jornay PM 20mg capsules (Bottle of 100)$10,971
- Quillivant$10,516
- Quillivant XR$2,600
- Azstarys$523
- JORNAY PM$130
How this compares
$43,923 in reported general payments places this provider in the 95th percentile of 908 pediatrics providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 17 | $385 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 15 | $284 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Mobile
- Hilary SeayMobile$5K
- Catherine HuettemannMobile$3K
- Richard HuettemannMobile$3K
- Windham TinnellMobile$3K
- Katherine SavellsMobile$2K
- Tamera Coyne-BeasleyBirmingham$154K
- Linda HammettBirmingham$123K
- Darby McElderryBirmingham$111K
- Audrey LloydBirmingham$40K
- Suresh BoppanaBirmingham$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.